Literature DB >> 35546540

Staphylococcus aureus Does Not Synthesize Arginine from Proline under Physiological Conditions.

Bohyun Jeong1,2, Majid Ali Shah2, Eunjung Roh3, Kyeongkyu Kim4, Indal Park1, Taeok Bae2.   

Abstract

The Gram-positive pathogen Staphylococcus aureus is the only bacterium known to synthesize arginine from proline via the arginine-proline interconversion pathway despite having genes for the well-conserved glutamate pathway. Since the proline-arginine interconversion pathway is repressed by CcpA-mediated carbon catabolite repression (CCR), CCR has been attributed to the arginine auxotrophy of S. aureus. Using ribose as a secondary carbon source, here, we demonstrate that S. aureus arginine auxotrophy is not due to CCR but due to the inadequate concentration of proline degradation product. Proline is degraded by proline dehydrogenase (PutA) into pyrroline-5-carboxylate (P5C). Although the PutA expression was fully induced by ribose, the P5C concentration remained insufficient to support arginine synthesis because P5C was constantly consumed by the P5C reductase ProC. When the P5C concentration was artificially increased by either PutA overexpression or proC deletion, S. aureus could synthesize arginine from proline regardless of carbon source. In contrast, when the P5C concentration was reduced by overexpression of proC, it inhibited the growth of the ccpA deletion mutant without arginine. Intriguingly, the ectopic expression of the glutamate pathway enzymes converted S. aureus into arginine prototroph. In an animal experiment, the arginine-proline interconversion pathway was not required for the survival of S. aureus. Based on these results, we concluded that S. aureus does not synthesize arginine from proline under physiological conditions. We also propose that arginine auxotrophy of S. aureus is not due to the CcpA-mediated CCR but due to the inactivity of the conserved glutamate pathway. IMPORTANCE Staphylococcus aureus is a versatile Gram-positive human pathogen infecting various human organs. The bacterium's versatility is partly due to efficient metabolic regulation via the carbon catabolite repression system (CCR). S. aureus is known to interconvert proline and arginine, and CCR represses the synthesis of both amino acids. However, when CCR is released by a nonpreferred carbon source, S. aureus can synthesize proline but not arginine. In this study, we show that, in S. aureus, the intracellular concentration of pyrroline-5-carboxylate (P5C), the degradation product of proline and the substrate of proline synthesis, is too low to synthesize arginine from proline. These results call into question the notion that S. aureus synthesizes arginine from proline.

Entities:  

Keywords:  CcpA; Staphylococcus aureus; arginine synthesis; carbon catabolite repression

Mesh:

Substances:

Year:  2022        PMID: 35546540      PMCID: PMC9210973          DOI: 10.1128/jb.00018-22

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.476


  34 in total

1.  Ligation-independent cloning of PCR products (LIC-PCR).

Authors:  C Aslanidis; P J de Jong
Journal:  Nucleic Acids Res       Date:  1990-10-25       Impact factor: 16.971

Review 2.  Methicillin-resistant Staphylococcus aureus.

Authors:  Andie S Lee; Hermínia de Lencastre; Javier Garau; Jan Kluytmans; Surbhi Malhotra-Kumar; Andreas Peschel; Stephan Harbarth
Journal:  Nat Rev Dis Primers       Date:  2018-05-31       Impact factor: 52.329

3.  Staphylococcus aureus CcpA affects virulence determinant production and antibiotic resistance.

Authors:  Kati Seidl; Martin Stucki; Martin Ruegg; Christiane Goerke; Christiane Wolz; Llinos Harris; Brigitte Berger-Bächi; Markus Bischoff
Journal:  Antimicrob Agents Chemother       Date:  2006-04       Impact factor: 5.191

4.  The toxic shock syndrome exotoxin structural gene is not detectably transmitted by a prophage.

Authors:  B N Kreiswirth; S Löfdahl; M J Betley; M O'Reilly; P M Schlievert; M S Bergdoll; R P Novick
Journal:  Nature       Date:  1983 Oct 20-26       Impact factor: 49.962

5.  A Membrane-Bound Transcription Factor is Proteolytically Regulated by the AAA+ Protease FtsH in Staphylococcus aureus.

Authors:  Won-Sik Yeo; Chiamara Anokwute; Philip Marcadis; Marcus Levitan; Mahmoud Ahmed; Yeun Bae; Kyeongkyu Kim; Tatiana Kostrominova; Qian Liu; Taeok Bae
Journal:  J Bacteriol       Date:  2020-04-09       Impact factor: 3.490

6.  Low-proline environments impair growth, proline transport and in vivo survival of Staphylococcus aureus strain-specific putP mutants.

Authors:  William R Schwan; Keith J Wetzel; Timothy S Gomez; Melissa A Stiles; Brian D Beitlich; Sandra Grunwald
Journal:  Microbiology       Date:  2004-04       Impact factor: 2.777

Review 7.  The arginine repressor of Escherichia coli.

Authors:  W K Maas
Journal:  Microbiol Rev       Date:  1994-12

8.  Staphylococcus aureus secretes a unique class of neutrophil serine protease inhibitors.

Authors:  Daphne A C Stapels; Kasra X Ramyar; Markus Bischoff; Maren von Köckritz-Blickwede; Fin J Milder; Maartje Ruyken; Janina Eisenbeis; William J McWhorter; Mathias Herrmann; Kok P M van Kessel; Brian V Geisbrecht; Suzan H M Rooijakkers
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-26       Impact factor: 11.205

9.  Staphylococcus aureus virulence genes identified by bursa aurealis mutagenesis and nematode killing.

Authors:  Taeok Bae; Alison K Banger; Adam Wallace; Elizabeth M Glass; Fredrik Aslund; Olaf Schneewind; Dominique M Missiakas
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-10       Impact factor: 11.205

10.  Staphylococcus aureus Transcriptome Architecture: From Laboratory to Infection-Mimicking Conditions.

Authors:  Ulrike Mäder; Pierre Nicolas; Maren Depke; Jan Pané-Farré; Michel Debarbouille; Magdalena M van der Kooi-Pol; Cyprien Guérin; Sandra Dérozier; Aurelia Hiron; Hanne Jarmer; Aurélie Leduc; Stephan Michalik; Ewoud Reilman; Marc Schaffer; Frank Schmidt; Philippe Bessières; Philippe Noirot; Michael Hecker; Tarek Msadek; Uwe Völker; Jan Maarten van Dijl
Journal:  PLoS Genet       Date:  2016-04-01       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.